XML 59 R51.htm IDEA: XBRL DOCUMENT v3.25.1
Equity-Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Aug. 20, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Equity-based compensation expense $ 14,234 $ 11,968  
Research and Development Expense      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Equity-based compensation expense 7,546 6,083  
General and Administrative      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Equity-based compensation expense 6,688 5,885  
Employee Stock Option      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Intrinsic value of stock options exercised $ 2,100 $ 6,800  
Weighted-average fair value of options granted $ 20.66 $ 26.53  
Unrecognized stock-based compensation expense $ 87,900    
Unrecognized compensation cost, recognition period 2 years 2 months 12 days    
Equity-based compensation expense $ 11,570 $ 10,362  
Employee Stock Option | Research and Development Expense      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Equity-based compensation expense 5,713 5,040  
Employee Stock Option | General and Administrative      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Equity-based compensation expense 5,857 $ 5,322  
Restricted Stock      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Unrecognized stock-based compensation expense $ 24,600    
Unrecognized compensation cost, recognition period 2 years 4 months 24 days    
Granted 327,800 231,834  
Equity-based compensation expense $ 2,400 $ 1,400  
Restricted Stock | Research and Development Expense      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Equity-based compensation expense 1,600 900  
Restricted Stock | General and Administrative      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Equity-based compensation expense 800 $ 500  
Performance Stock      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Unrecognized stock-based compensation expense $ 0    
2020 Plan      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of shares authorized for issuance under plan     4,457,370
Maximum number of shares to be issued, percentage 4.00%    
Shares remaining available for future grants 4,606,684    
Performance stock options vesting 40.00%    
Second clinical milestone vesting percentage 40.00%    
Third clinical milestone vesting percentage 20.00%    
Granted 88,000    
Option Indexed to Issuer's Equity, Strike Price $ 30.17    
Performance stock options outstanding 88,000    
2020 Plan | Restricted Stock      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Granted 285,723 0  
2020 Plan | Performance Stock      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Performance stock options vesting 40.00%    
Second clinical milestone vesting percentage 40.00%    
Third clinical milestone vesting percentage 20.00%    
Option Indexed to Issuer's Equity, Strike Price $ 30.17    
2020 Plan | Minimum [Member]      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Performance stock options range 0.00%    
2020 Plan | Minimum [Member] | Performance Stock      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Performance stock options range 0.00%    
2020 Plan | Maximum [Member]      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Performance stock options range 100.00%    
2020 Plan | Maximum [Member] | Performance Stock      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Performance stock options range 100.00%    
2020 ESPP      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of shares authorized for issuance under plan     445,653
Shares remaining available for future grants 2,363,127    
Share-based compensation, description The 2020 ESPP initially reserved and authorized the issuance of up to a total of 445,653 shares of common stock to participating employees. The 2020 ESPP provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2021 and each January 1 thereafter through January 1, 2030, by the lesser of (i) 438,898 shares of common stock, (ii) 1% of the Company’s outstanding number of shares of common stock on the immediately preceding December 31 or (iii) such lesser number of shares of common stock as determined by the administrator of the 2020 ESPP    
2020 ESPP | Lesser of Potential Outcome 1      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Maximum number of shares to be issued, percentage 1.00%    
Number of additional shares authorized 438,898    
2018 Plan | Restricted Stock      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Granted 613,523